These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 35747825)

  • 1. The Potential Role of Exosomal Proteins in Prostate Cancer.
    Feng S; Lou K; Zou X; Zou J; Zhang G
    Front Oncol; 2022; 12():873296. PubMed ID: 35747825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomal particles secreted by prostate cancer cells are potent mRNA and protein vehicles for the interference of tumor and tumor environment.
    Rauschenberger L; Staar D; Thom K; Scharf C; Venz S; Homuth G; Schlüter R; Brandenburg LO; Ziegler P; Zimmermann U; Weitschies W; Völker U; Lendeckel U; Walther R; Burchardt M; Stope MB
    Prostate; 2016 Mar; 76(4):409-24. PubMed ID: 26643154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomal miRNAs as novel cancer biomarkers: Challenges and opportunities.
    Salehi M; Sharifi M
    J Cell Physiol; 2018 Sep; 233(9):6370-6380. PubMed ID: 29323722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomal circRNAs: Emerging Players in Tumor Metastasis.
    Zhou H; He X; He Y; Ou C; Cao P
    Front Cell Dev Biol; 2021; 9():786224. PubMed ID: 34957113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomes as biomarker enriched microvesicles: characterization of exosomal proteins derived from a panel of prostate cell lines with distinct AR phenotypes.
    Hosseini-Beheshti E; Pham S; Adomat H; Li N; Tomlinson Guns ES
    Mol Cell Proteomics; 2012 Oct; 11(10):863-85. PubMed ID: 22723089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomal circRNAs as novel cancer biomarkers: Challenges and opportunities.
    Wang S; Dong Y; Gong A; Kong H; Gao J; Hao X; Liu Y; Wang Z; Fan Y; Liu C; Xu W
    Int J Biol Sci; 2021; 17(2):562-573. PubMed ID: 33613113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoscale flow cytometry to distinguish subpopulations of prostate extracellular vesicles in patient plasma.
    Padda RS; Deng FK; Brett SI; Biggs CN; Durfee PN; Brinker CJ; Williams KC; Leong HS
    Prostate; 2019 May; 79(6):592-603. PubMed ID: 30680751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomes in diagnosis and therapy of prostate cancer.
    Pan J; Ding M; Xu K; Yang C; Mao LJ
    Oncotarget; 2017 Nov; 8(57):97693-97700. PubMed ID: 29228644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer.
    Valentino A; Reclusa P; Sirera R; Giallombardo M; Camps C; Pauwels P; Crispi S; Rolfo C
    Clin Transl Oncol; 2017 Jun; 19(6):651-657. PubMed ID: 28054319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor efficacy of interferon-γ-modified exosomal vaccine in prostate cancer.
    Shi X; Sun J; Li H; Lin H; Xie W; Li J; Tan W
    Prostate; 2020 Aug; 80(11):811-823. PubMed ID: 32427375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-Derived Exosomes: Their Role in Cancer Biology and Biomarker Development.
    Kok VC; Yu CC
    Int J Nanomedicine; 2020; 15():8019-8036. PubMed ID: 33116515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomal tetraspanins as regulators of cancer progression and metastasis and novel diagnostic markers.
    Malla RR; Pandrangi S; Kumari S; Gavara MM; Badana AK
    Asia Pac J Clin Oncol; 2018 Dec; 14(6):383-391. PubMed ID: 29575602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological functions and clinical applications of exosomal long non-coding RNAs in cancer.
    Wang Y; Zhang M; Zhou F
    J Cell Mol Med; 2020 Oct; 24(20):11656-11666. PubMed ID: 32924276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging Functions and Clinical Applications of Exosomal ncRNAs in Ovarian Cancer.
    Zhang Y; Wei YJ; Zhang YF; Liu HW; Zhang YF
    Front Oncol; 2021; 11():765458. PubMed ID: 34804970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preliminary study on the diagnostic value of serum-derived exosomal lncRNA in epithelial ovarian cancer].
    Li YW; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2022 Mar; 57(3):198-209. PubMed ID: 35385957
    [No Abstract]   [Full Text] [Related]  

  • 16. The emerging roles of exosomal long non-coding RNAs in bladder cancer.
    Liu Q
    J Cell Mol Med; 2022 Feb; 26(4):966-976. PubMed ID: 34981655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of exosomes and their cargo in drug response/resistance of breast cancer patients.
    Schwarzenbach H; Gahan PB
    Cancer Drug Resist; 2020; 3(1):63-82. PubMed ID: 35582044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging Function and Clinical Significance of Exosomal circRNAs in Cancer.
    Wang M; Yu F; Li P; Wang K
    Mol Ther Nucleic Acids; 2020 Sep; 21():367-383. PubMed ID: 32650235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the study of exosomal lncRNAs in tumors and the selection of research methods.
    Wu Y; Wang Y; Wei M; Han X; Xu T; Cui M
    Biomed Pharmacother; 2020 Mar; 123():109716. PubMed ID: 31896067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The emerging roles of exosomal circRNAs in diseases.
    Guo X; Tan W; Wang C
    Clin Transl Oncol; 2021 Jun; 23(6):1020-1033. PubMed ID: 32935262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.